Diatech Pharmacogenetics is pleased to announce its new Continuing Medical Education project “Carcinoma Uroteliale Metastatico 2.0. Nuove prospettive terapeutiche della medicina di precisione”, co-sponsored with Johnson&Johnson
Don’ t miss it on December 15 at 3.00 PM.
The content you are about to access is intended for other markets and may include products or information not available in the U.S. or Canada.
Please select your region to access the content that is most relevant to your location and applicable regulations.